Panbela Therapeutics, Inc (PBLA)
NCM · Common · CUSIP 69833Q100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PBLA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
69833Q100 (prev. 86664M206 )
Market Cap
Micro Cap
Previous Symbol
SNBP (changed 12/2/2020)
Previous Name
Sun BioPharma, Inc.
Business: Panbela Therapeutics, Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for urgent unmet medical needs. Its current focus is on the treatment of patients with pancreatic cancer.
Notes: January 13, 2023, The Company effected a 1-for-40 reverse stock split of our outstanding shares of common stock.

Company Contact

CEO
Jennifer K. Simpson
CFO
Susan Horvath
Headquarters
712 Vista Blvd #305, Waconia, MN 55387
Phone
952-479-1196
Investor Relations
James Carbonara, Hayden IR · 646-755-7412 · james@haydenir.com
General Email
IR@sunbiopharma.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »